MICROSENS
Microsens Diagnostics (MD) was established to exploit an established technology and patent portfolio in the field of diagnostics. The technology fulfils an unmet need in the development of point of care tests and automated sample extraction methods. MD has an initial focus and extensive collaborations with commercial partners on tuberculosis and MRSA. Sales of the MD technology into the TB market (marketed as TB-Beads) have already been made.
MICROSENS
Industry:
Biotechnology Health Care Information Technology
Founded:
2013-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.microsensdx.com
Status:
Active
Contact:
+44 (0)20 76912147
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Apache Global Site Tag Sitelinks Search Box
Official Site Inspections
http://www.microsensdx.com
- Host name: srv5.host-my-site1.co.uk
- IP address: 185.211.23.74
- Location: Ballyclare United Kingdom
- Latitude: 54.7682
- Longitude: -6.0186
- Timezone: Europe/London
- Postal: BT39
More informations about "Microsens"
MicrosensDx Ltd – MicrosensDx
"MicrosensDx are a plucky company with a small team of professional and very dynamic staff who have great knowledge of the products and services they provide. They are friendly and …See details»
About us – MicrosensDx Ltd
MicrosensDx offers sample collection, enrichment and preparation services and products to diagnostic companies and clinical testing laboratories. The …See details»
MicrosensDx
MicrosensDx is a dynamic and ambitious organisation, built from a solid base back in 2001. With three patent families covering sample preparation, protein aggregation and …See details»
Management Team – MicrosensDx Ltd
Frankie joined MicrosensDX in 2009 and with this extensive experience, plays a key cross-functional role across many areas of the business. She is the primary contact for all first line …See details»
MicrosensDx - Crunchbase Company Profile & Funding
MicrosensDx focuses on delivering the sample result in molecular solutions that transforms patient outcomes. MicrosensDx was founded in 1999 and was headquartered in London, …See details»
MicrosensDx - LinkedIn
MicrosensDx has expertise in the design and manufacture of sample preparation products that help drive diagnostics. MicrosensDx empowers infectious disease diagnostics.See details»
MicrosensDx - Cambridge Science Park
MicrosensDx is a dynamic and ambitious innovator at the leading edge of the diagnostics sector for more than 20 years. MicrosensDX is building a global brand, delivering sample to result molecular solutions, transforming patient …See details»
MICROSENSDX LIMITED overview - Find and update company …
MICROSENSDX LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Microsens - Overview, News & Competitors | ZoomInfo.com
MicrosensDx is a dynamic and ambitious innovator, at the leading edge of the diagnostics sector for more than 20 years. Headquartered in Cambridge, close to one of the UK's most dynamic …See details»
Sepsis – MicrosensDx Ltd
Find out more about P Complex, collaboration opportunities and its potential in sepsis and patient management by contacting us at [email protected]. *Global report on the epidemiology …See details»
Microsens DX - FS Ventures
With more than fifteen years of experience in addressing unmet needs in diagnostic markets, Microsens has developed low cost, easy to use, and easily automatable extraction …See details»
MicrosensDx collaborates with Imperial researchers to develop ...
Sep 17, 2024 · MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.See details»
MicrosensDx collaborates with Imperial researchers to develop …
Sep 13, 2024 · MicrosensDx has announced that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.See details»
MicrosensDx : Quotes, Address, Contact - News-Medical.net
With simple, fast and scalable pan-sample nucleic acid extraction; high performance sample collection, stabilisation and inactivation through to the novel technology for inflammation and …See details»
MicrosensDx collaborates with Imperial researchers to develop ...
Sep 13, 2024 · MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.See details»
Investors – MicrosensDx Ltd
MicrosensDx is developing its novel sepsis IP, P Complex - to confront a profound unmet medical need, to improve sepsis diagnosis and prognosis testing. Its prospective routine early warning …See details»
The very latest in sepsis diagnostic innovation with MicrosensDx …
Oct 31, 2024 · Simon Walker, CEO of MicrosensDx, discusses the collaboration with The Mayr Group at Imperial College London to develop a groundbreaking sepsis test. This innovative …See details»
Microsens Company Profile - Office Locations, Competitors ... - Craft
See insights on Microsens including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
A promising solution to identify risk of sepsis – MicrosensDx Ltd
MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.See details»
MicrosensDx
MicrosensDx — Supplier from UK, has experience with The Seventh Framework Programme, Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement sectorsSee details»